These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 8100832

  • 1. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY, Sheu WH, Jaspan JB, Polonsky KS, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [Abstract] [Full Text] [Related]

  • 2. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.
    Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):106-10. PubMed ID: 3536980
    [Abstract] [Full Text] [Related]

  • 3. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [Abstract] [Full Text] [Related]

  • 4. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D, Luyckx AS, Lefebvre PJ.
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [Abstract] [Full Text] [Related]

  • 5. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [Abstract] [Full Text] [Related]

  • 6. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 7. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.
    Chen YD, Golay A, Swislocki AL, Reaven GM.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):17-21. PubMed ID: 3782431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL, Compagnie MJ, Dellenbach P, Stephan F.
    Nouv Presse Med; 1980 Sep 13; 9(32):2247-51. PubMed ID: 6106923
    [Abstract] [Full Text] [Related]

  • 11. Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance?
    Wu MS, Jeng CY, Hollenbeck CB, Chen YD, Jaspan J, Reaven GM.
    J Clin Endocrinol Metab; 1990 Feb 13; 70(2):410-6. PubMed ID: 1967614
    [Abstract] [Full Text] [Related]

  • 12. Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism.
    Chambrier C, Picard S, Vidal H, Cohen R, Riou JP, Beylot M.
    Metabolism; 1990 Sep 13; 39(9):976-84. PubMed ID: 1975421
    [Abstract] [Full Text] [Related]

  • 13. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC, Fuh MM, Shieh SM, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1991 Sep 13; 73(3):503-10. PubMed ID: 1874929
    [Abstract] [Full Text] [Related]

  • 14. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M, Grill V, Efendić S.
    J Clin Endocrinol Metab; 1986 Jan 13; 62(1):77-83. PubMed ID: 2866196
    [Abstract] [Full Text] [Related]

  • 15. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
    Paolisso G, Sgambato S, Gentile S, Memoli P, Giugliano D, Varricchio M, D'Onofrio F.
    J Clin Endocrinol Metab; 1988 Nov 13; 67(5):1005-10. PubMed ID: 3053747
    [Abstract] [Full Text] [Related]

  • 16. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.
    Metabolism; 1993 Oct 13; 42(10):1242-8. PubMed ID: 8105365
    [Abstract] [Full Text] [Related]

  • 17. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O, Miles P, Wasserman D, Lickley L, Vranic M.
    J Clin Invest; 1988 Jun 13; 81(6):1759-67. PubMed ID: 3290252
    [Abstract] [Full Text] [Related]

  • 18. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O.
    Diabetologia; 1991 Jul 13; 34(7):521-6. PubMed ID: 1916058
    [Abstract] [Full Text] [Related]

  • 19. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K, Steil GM, Mittelman SD, Bergman RN.
    J Clin Invest; 1996 Aug 01; 98(3):741-9. PubMed ID: 8698866
    [Abstract] [Full Text] [Related]

  • 20. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
    Mauriège P, Klein Kranenbarg WM, Prud'homme D, Lamarche B, Tremblay A, Bouchard C, Nadeau A, Després JP.
    Int J Obes Relat Metab Disord; 1996 Jul 01; 20(7):668-76. PubMed ID: 8817361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.